Threes Company: Regulation of Cell Fate by Statins
Journal:
Current Drug Targets - Cardiovascular & Hematological Disorders
Volume:
5
Page:
145-163
Author(s):
Joannis E. Vamvakopoulos
Augmenting T Helper Cell Immunity in Cancer
Journal:
Current Drug Targets - Immune, Endocrine & Metabolic Disorders
Volume:
5
Page:
365-371
Author(s):
K. L. Knutson and M. L. Disis
Failure of Immune Homeostasis - The Consequences of Under and Over Reactivity
Journal:
Current Drug Targets - Immune, Endocrine & Metabolic Disorders
Volume:
5
Page:
413-423
Author(s):
B. Crimeen-Irwin, K. Scalzo, S. Gloster, P. L. Mottram and M. Plebanski
Multiple Mechanisms of Cytokine Action in Neurodegenerative and Psychiatric States: Neurochemical and Molecular Substrates
Journal:
Current Pharmaceutical Design
Volume:
11
Page:
947-962
Author(s):
Shawn Hayley and Hymie Anisman
Ghrelin and Energy Balance: Focus on Current Controversies
Journal:
Current Drug Targets
Volume:
6
Page:
153-169
Author(s):
David E. Cummings, Karen E. Foster-Schubert and Joost Overduin
Functional Characteristic of Snake Venom Disintegrins: Potential Therapeutic Implication
Journal:
Current Pharmaceutical Design
Volume:
11
Page:
815-827
Author(s):
Cezary Marcinkiewicz
Structure-Function Correlations of Snake Venom Disintegrins&#
Journal:
Current Pharmaceutical Design
Volume:
11
Page:
829-835
Author(s):
Juan J. Calvete
ADAM-Integrin Interactions: Potential Integrin Regulated Ectodomain Shedding Activity
Journal:
Current Pharmaceutical Design
Volume:
11
Page:
837-847
Author(s):
Lance C. Bridges and Ron D. Bowditch
Collagen-Binding Integrins as Pharmaceutical Targets
Journal:
Current Pharmaceutical Design
Volume:
11
Page:
867-880
Author(s):
Johannes A. Eble
Integrins: Regulators of Tissue Function and Cancer Progression
Journal:
Current Pharmaceutical Design
Volume:
11
Page:
881-891
Author(s):
Erik H.J. Danen